Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
发明人:
Michael R. YEAMAN,Nannette Y. YOUNT,Eric P. BRASS
申请号：
US14609128
公开号：
US20150232521A1
申请日:
2015.01.29
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention provide isolated peptides, protides and conjugates having novel peptide sequences which are able to induce antimicrobial, anti-cancer, anti-inflammatory, anti-proliferative or programmed cell death activity. The invention also provides a method of inducing programmed cell death in a cell by contacting the cell with an isolated peptide, protide or conjugate described herein. In some aspects, the method can be used in the diagnosis, prevention, or treatment of a disease, such as an infection, cancer, autoimmune disease, or inflammatory disease.
